Also check out
"Advancing continuous subcutaneous insulin infusion in vivo:New insights into tissue challenges" by Ulrike Klueh and her lab in J. Biomed Mater Research, 2020, p 1. I don't know if you can get it for free but her findings are the same pretty much the same. Her conclusions are " As...
The article is by Hakan Erikson (the forum thinks the link is spam) at Lund. You can see it at Biotechnology Techniques, 1998 p 329. The fact that the paper is 22 years old and no products have appeared in that time frame suggests that perhaps it is not as trivial as it might seem
A discussion of how a zeolite COULD be used as a filter to remove phenol. There is increasing evidence that phenolic preservatives might lead to premature site loss for pump patients i.e. unexplained hyperglycemia. Certainly there is evidence that phenolics can cause tissue irritation even in...
Kang S, Creagh FM, Peters JR et al. (1991) Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type 1 diabetic subjects. Diabetes Care 14: 571±577
Actually it is a bit more complicated rather than simple. Phenolic preservatives are included in insulin formulation to keep bacteria from growing in the vial and to kill any bacteria that you might inject through the skin. To have "bacterial efficacy" means that you will kill all of the...